KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Return on Sales (2016 - 2024)

Novartis Ag's Return on Sales history spans 13 years, with the latest figure at 0.0% for Q2 2024.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q2 2024 year-over-year; TTM through Jun 2024 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q2 2024 for Novartis Ag, up from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for NVS hit a ceiling of 0.2% in Q4 2020 and a floor of 0.0% in Q2 2023.
  • Historically, Return on Sales has averaged 0.02% across 5 years, with a median of 0.01% in 2022.
  • Biggest five-year swings in Return on Sales: rose 1bps in 2020 and later decreased -20bps in 2021.
  • Tracing NVS's Return on Sales over 5 years: stood at 0.2% in 2020, then plummeted by -99bps to 0.0% in 2021, then skyrocketed by 320bps to 0.01% in 2022, then crashed by -99bps to 0.0% in 2023, then surged by 3493bps to 0.0% in 2024.
  • Business Quant data shows Return on Sales for NVS at 0.0% in Q2 2024, 0.0% in Q4 2023, and 0.0% in Q2 2023.